Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.73 USD | -3.35% | +1.76% | -42.52% |
05-10 | Ocuphire Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-11 | Ocuphire Pharma Enrolls 1st Patient in Phase 3 Trial of Visual Acuity Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.52% | 44.3M | |
+37.78% | 723B | |
+30.88% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.62% | 244B | |
-4.62% | 208B | |
+10.13% | 210B | |
+9.32% | 169B |
- Stock Market
- Equities
- OCUP Stock
- News Ocuphire Pharma, Inc.
- Alliance Global Partners Cuts Price Target on Ocuphire Pharma to $20 From $24, Maintains Buy Rating